The immunobiology and clinical features of type 1 autoimmune polyglandular syndrome (APS-1).
Guo CJ, Leung PSC, Zhang W, Ma X, Gershwin ME.
Autoimmun Rev. 2018 Jan;17(1):78-85. doi: 10.1016/j.autrev.2017.11.012. Epub 2017 Nov 4.
Autoimmune polyendocrine syndrome induced by immune checkpoint inhibitors: a systematic review.
Zhao Z, Wang X, Bao XQ, Ning J, Shang M, Zhang D.
Cancer Immunol Immunother. 2021 Jun;70(6):1527-1540. doi: 10.1007/s00262-020-02699-1. Epub 2020 Nov 16.
Impaired salivary gland activity in patients with autoimmune polyendocrine syndrome type I.
Oftedal BE, Marthinussen MC, Erichsen MM, Tveitarås MK, Kjellesvik-Kristiansen A, Hammenfors D, Jonsson MV, Kisand K, Jonsson R, Wolff ASB.
Autoimmunity. 2017 Jun;50(4):211-222. doi: 10.1080/08916934.2017.1344972. Epub 2017 Jul 7.
Autoimmune polyendocrine syndrome type 1 and NALP5, a parathyroid autoantigen.
Alimohammadi M, Björklund P, Hallgren A, Pöntynen N, Szinnai G, Shikama N, Keller MP, Ekwall O, Kinkel SA, Husebye ES, Gustafsson J, Rorsman F, Peltonen L, Betterle C, Perheentupa J, Akerström G, Westin G, Scott HS, Holländer GA, Kämpe O.
N Engl J Med. 2008 Mar 6;358(10):1018-28. doi: 10.1056/NEJMoa0706487.
Autoimmune polyglandular syndrome type 2: A case report.
Bakkour A, Zakkor MD, Taha Khairy L, Horo R, Mohammed Sharif Ahmed E, Alhussein H.
Ann Med Surg (Lond). 2022 May 16;78:103742. doi: 10.1016/j.amsu.2022.103742. eCollection 2022 Jun.
AIRE-mutations and autoimmune disease.
Bruserud Ø, Oftedal BE, Wolff AB, Husebye ES.
Curr Opin Immunol. 2016 Dec;43:8-15. doi: 10.1016/j.coi.2016.07.003. Epub 2016 Aug 6.
Fungi and Endocrine Dysfunction.
Bhattacharya S, Kubiha S, Tyagi P.
2021 Jun 25. In: Feingold KR, Ahmed SF, Anawalt B, Blackman MR, Boyce A, Chrousos G, Corpas E, de Herder WW, Dhatariya K, Dungan K, Hofland J, Kalra S, Kaltsas G, Kapoor N, Koch C, Kopp P, Korbonits M, Kovacs CS, Kuohung W, Laferrère B, Levy M, McGee EA, McLachlan R, Muzumdar R, Purnell J, Rey R, Sahay R, Shah AS, Singer F, Sperling MA, Stratakis CA, Trence DL, Wilson DP, editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000–.
Introduction: Autoimmune polyendocrine syndrome type 1 (APS-1): a rare monogenic disorder as a model to improve understanding of tolerance and autoimmunity.
Kämpe O.
J Intern Med. 2009 May;265(5):511-3. doi: 10.1111/j.1365-2796.2009.02094.x.
A Case of Autoimmune Polyendocrine Syndrome Type 3B and Peripheral Neuropathy Due to Thiamine Deficiency.
Suzuki A, Hayashi K, Hayashi M, Nakaya Y, Sato M.
Cureus. 2024 Jan 11;16(1):e52123. doi: 10.7759/cureus.52123. eCollection 2024 Jan.
Psoriasis in autoimmune polyendocrine syndrome type I: a possible complication or a non-endocrine minor component?
Poojary SA, Lodha N, Gupta N.
Indian J Dermatol Venereol Leprol. 2015 Mar-Apr;81(2):166-9. doi: 10.4103/0378-6323.152285.
